Comment on: Boden et al. (2007) combined use of rosiglitazone and fenofibrate in patients with type 2 diabetes: Prevention of fluid retention: Diabetes 56:248-255 [1]

Research output: Contribution to journalLetter

Original languageEnglish
Pages (from-to)e1
JournalDiabetes
Volume56
Issue number5
DOIs
StatePublished - 1 May 2007

Cite this